In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

Signs and symptoms of age-related macular degeneration (AMD) are important to spot to prevent further deterioration of sight.

Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.

For more information on Age-Related Macular Degeneration go to the NHS website. If you've had a diagnosis, in addition to ...

For those who smoke, this long-term habit can damage parts of your eye, contributing to serious conditions such as macular ...

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

D Molecular (FDMT) presented 52-week wet age-related macular degeneration Phase IIb results at this weekend’s Angiogenesis, Exudation, and ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

The following is a summary of “High Density Lipoproteins Associate with Age-Related Macular Degeneration in the All of Us Research Program,” published in the January 2025 issue of Ophthalmology by ...